Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Healthcare Corporation
FDA Inspection
•Baxter Healthcare Corporation•April 2, 2026

Baxter Healthcare Corporation – FDA Inspection, Apr 2, 2026

Record Details

This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on April 2, 2026, issued by the Chicago District Office, covering human drugs.

Company
Baxter Healthcare Corporation
Inspection Date
April 2, 2026
Product Type
Human Drugs
Office
Chicago District Office
People
  • Logan T. Williams (Investigator)
  • Paranthaman Senthamarai Kannan
  • Robert J. Ham (FDA Associated Person)
  • Supreet K. Sran (Issuing Officer)
  • Supreet K. Stan (Issuing Officer)
View Company Profile

ID · 290eecce-a29f-4780-a2bd-0bf2db56f133

Inspection Facts

Inspection number
1311078
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

9
  1. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.160(a)Following/documenting laboratory controls
  4. 21 CFR 211.165(d)Acceptance/Rejection Levels
  5. 21 CFR 211.192Investigations of discrepancies, failures
  6. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  7. 21 CFR 211.42(c)Defined areas of adequate size for operations
  8. 21 CFR 211.63Equipment Design, Size and Location
  9. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Healthcare Corporation

19
DateClassificationOfficeProject area
November 25, 2025Not classifiedChicago District OfficeBlood and Blood Products
August 1, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 18, 2023VAICenter for Devices and Radiological HealthCompliance: Devices
September 26, 2018Not classifiedChicago District Office
July 14, 2017VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 19 other inspections on the company page
Other documents for Baxter Healthcare Corporation
  • FDA Inspection 1293034 - 2025-11-25
  • FDA Inspection 1243362 - 2024-08-01
  • FDA Inspection 1215194 - 2023-08-18
  • FDA Inspection 1068273 - 2018-09-26
  • FDA Inspection 1024072 - 2017-07-14

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Healthcare Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.